{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:52:19Z","timestamp":1794016339546,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type I and III interferons (IFN-I\/\u03bb) are important antiviral mediators against SARS-CoV-2 infection. Here, we demonstrate that plasmacytoid dendritic cells (pDC) are the predominant IFN-I\/\u03bb source following their sensing of SARS-CoV-2-infected cells. Mechanistically, this short-range sensing by pDCs requires sustained integrin-mediated cell adhesion with infected cells. In turn, pDCs restrict viral spread by an IFN-I\/\u03bb response directed toward SARS-CoV-2-infected cells. This specialized function enables pDCs to efficiently turn-off viral replication, likely via a local response at the contact site with infected cells. By exploring the pDC response in SARS-CoV-2 patients, we further demonstrate that pDC responsiveness inversely correlates with the severity of the disease. The pDC response is particularly impaired in severe COVID-19 patients. Overall, we propose that pDC activation is essential to control SARS-CoV-2-infection. Failure to develop this response could be important to understand severe cases of COVID-19.<\/jats:p>","DOI":"10.1038\/s41467-023-36140-9","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T15:04:04Z","timestamp":1675868644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5065-8463","authenticated-orcid":false,"given":"Manon","family":"Venet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-9728","authenticated-orcid":false,"given":"Margarida Sa","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-6320","authenticated-orcid":false,"given":"Elodie","family":"D\u00e9cembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Nuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-8993","authenticated-orcid":false,"given":"Marine","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-8765","authenticated-orcid":false,"given":"David","family":"Cluet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Pescamona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-4365","authenticated-orcid":false,"given":"Helena","family":"Paidassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-8179","authenticated-orcid":false,"given":"Thierry","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2539-972X","authenticated-orcid":false,"given":"Omran","family":"Allatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-5332","authenticated-orcid":false,"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Trouillet-Assant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-5837","authenticated-orcid":false,"given":"Emiliano P.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-4796","authenticated-orcid":false,"given":"Marl\u00e8ne","family":"Dreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"36140_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907\u2013923 (2019).","journal-title":"Immunity"},{"key":"36140_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","volume":"53","author":"YM Kim","year":"2021","unstructured":"Kim, Y. M. & Shin, E. C. Type I and III interferon responses in SARS-CoV-2 infection. Exp. Mol. Med. 53, 750\u2013760 (2021).","journal-title":"Exp. Mol. Med."},{"key":"36140_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri3806","volume":"15","author":"J Crouse","year":"2015","unstructured":"Crouse, J., Kalinke, U. & Oxenius, A. Regulation of antiviral T cell responses by type I interferons. Nat. Rev. Immunol. 15, 231\u2013242 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"36140_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fimmu.2017.00259","volume":"8","author":"S Makris","year":"2017","unstructured":"Makris, S., Paulsen, M. & Johansson, C. Type I interferons as regulators of lung inflammation. Front. Immunol. 8, 259 (2017).","journal-title":"Front. Immunol."},{"key":"36140_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221\u2013236 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"36140_CR6","doi-asserted-by":"publisher","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","volume":"16","author":"M Sa Ribero","year":"2020","unstructured":"Sa Ribero, M., Jouvenet, N., Dreux, M. & Nisole, S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 16, e1008737 (2020).","journal-title":"PLoS Pathog."},{"key":"36140_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"36140_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.abd2208","volume":"369","author":"GE Grajales-Reyes","year":"2020","unstructured":"Grajales-Reyes, G. E. & Colonna, M. Interferon responses in viral pneumonias. Science 369, 626\u2013627 (2020).","journal-title":"Science"},{"key":"36140_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","volume":"146","author":"S Trouillet-Assant","year":"2020","unstructured":"Trouillet-Assant, S. et al. Type I IFN immunoprofiling in COVID-19 patients. J. Allergy Clin. Immunol. 146, 206\u2013208 e202 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"36140_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41556-021-00681-2","volume":"23","author":"M Saichi","year":"2021","unstructured":"Saichi, M. et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat. Cell Biol. 23, 538\u2013551 (2021).","journal-title":"Nat. Cell Biol."},{"key":"36140_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","volume":"27","author":"A Park","year":"2020","unstructured":"Park, A. & Iwasaki, A. Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe 27, 870\u2013878 (2020).","journal-title":"Cell Host Microbe"},{"key":"36140_CR12","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","volume":"19","author":"YQ Min","year":"2021","unstructured":"Min, Y. Q. et al. Immune evasion of SARS-CoV-2 from interferon antiviral system. Comput. Struct. Biotechnol. J. 19, 4217\u20134225 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"36140_CR13","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia, H. et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020).","journal-title":"Cell Rep."},{"key":"36140_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810 (2020).","journal-title":"Nat. Commun."},{"key":"36140_CR15","doi-asserted-by":"publisher","first-page":"28344","DOI":"10.1073\/pnas.2016650117","volume":"117","author":"L Miorin","year":"2020","unstructured":"Miorin, L. et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc. Natl. Acad. Sci. USA 117, 28344\u201328354 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36140_CR16","doi-asserted-by":"publisher","first-page":"108916","DOI":"10.1016\/j.celrep.2021.108916","volume":"34","author":"I Kimura","year":"2021","unstructured":"Kimura, I. et al. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 34, 108916 (2021).","journal-title":"Cell Rep."},{"key":"36140_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41423-020-00619-y","volume":"18","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell Mol. Immunol. 18, 945\u2013953 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"36140_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"36140_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"36140_CR20","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","volume":"34","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. Cell-type-specific immune dysregulation in severely Ill COVID-19 patients. Cell Rep. 34, 108590 (2021).","journal-title":"Cell Rep."},{"key":"36140_CR21","doi-asserted-by":"publisher","first-page":"e20211211","DOI":"10.1084\/jem.20211211","volume":"218","author":"J Lopez","year":"2021","unstructured":"Lopez, J. et al. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J. Exp. Med 218, e20211211 (2021).","journal-title":"J. Exp. Med"},{"key":"36140_CR22","doi-asserted-by":"publisher","first-page":"e20210554","DOI":"10.1084\/jem.20210554","volume":"218","author":"P Bastard","year":"2021","unstructured":"Bastard, P. et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J. Exp. Med 218, e20210554 (2021).","journal-title":"J. Exp. Med"},{"key":"36140_CR23","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).","journal-title":"Science"},{"key":"36140_CR24","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"36140_CR25","doi-asserted-by":"publisher","first-page":"eabl4340","DOI":"10.1126\/sciimmunol.abl4340","volume":"6","author":"P Bastard","year":"2021","unstructured":"Bastard, P. et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci. Immunol. 6, eabl4340 (2021).","journal-title":"Sci. Immunol."},{"key":"36140_CR26","doi-asserted-by":"publisher","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano, T. et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci. Immunol. 6, eabl4348 (2021).","journal-title":"Sci. Immunol."},{"key":"36140_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","volume":"42","author":"C King","year":"2021","unstructured":"King, C. & Sprent, J. Dual nature of type I interferons in SARS-CoV-2-induced inflammation. Trends Immunol. 42, 312\u2013322 (2021).","journal-title":"Trends Immunol."},{"key":"36140_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","volume":"50","author":"B Reizis","year":"2019","unstructured":"Reizis, B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity 50, 37\u201350 (2019).","journal-title":"Immunity"},{"key":"36140_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/eji.201142045","volume":"42","author":"E Esashi","year":"2012","unstructured":"Esashi, E., Bao, M., Wang, Y. H., Cao, W. & Liu, Y. J. PACSIN1 regulates the TLR7\/9-mediated type I interferon response in plasmacytoid dendritic cells. Eur. J. Immunol. 42, 573\u2013579 (2012).","journal-title":"Eur. J. Immunol."},{"key":"36140_CR30","doi-asserted-by":"publisher","first-page":"19973","DOI":"10.1073\/pnas.1014051107","volume":"107","author":"AL Blasius","year":"2010","unstructured":"Blasius, A. L. et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 19973\u201319978 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36140_CR31","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1126\/science.1187029","volume":"329","author":"M Sasai","year":"2010","unstructured":"Sasai, M., Linehan, M. M. & Iwasaki, A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329, 1530\u20131534 (2010).","journal-title":"Science"},{"key":"36140_CR32","doi-asserted-by":"publisher","first-page":"10050","DOI":"10.1128\/JVI.01692-16","volume":"90","author":"B Webster","year":"2016","unstructured":"Webster, B., Assil, S. & Dreux, M. Cell-cell sensing of viral infection by plasmacytoid dendritic cells. J. Virol. 90, 10050\u201310053 (2016).","journal-title":"J. Virol."},{"key":"36140_CR33","doi-asserted-by":"publisher","first-page":"e1004434","DOI":"10.1371\/journal.ppat.1004434","volume":"10","author":"E Decembre","year":"2014","unstructured":"Decembre, E. et al. Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells. PLoS Pathog. 10, e1004434 (2014).","journal-title":"PLoS Pathog."},{"key":"36140_CR34","doi-asserted-by":"publisher","first-page":"e20201387","DOI":"10.1084\/jem.20201387","volume":"218","author":"F Onodi","year":"2021","unstructured":"Onodi, F. et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J. Exp. Med. 218, e20201387 (2021).","journal-title":"J. Exp. Med."},{"key":"36140_CR35","doi-asserted-by":"publisher","first-page":"e1009878","DOI":"10.1371\/journal.ppat.1009878","volume":"17","author":"M Severa","year":"2021","unstructured":"Severa, M. et al. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog. 17, e1009878 (2021).","journal-title":"PLoS Pathog."},{"key":"36140_CR36","doi-asserted-by":"publisher","first-page":"e109622","DOI":"10.15252\/embj.2021109622","volume":"41","author":"RM van der Sluis","year":"2022","unstructured":"van der Sluis, R. M. et al. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection. EMBO J. 41, e109622 (2022).","journal-title":"EMBO J."},{"key":"36140_CR37","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/JVI.01281-09","volume":"84","author":"J Chen","year":"2010","unstructured":"Chen, J. et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 84, 1289\u20131301 (2010).","journal-title":"J. Virol."},{"key":"36140_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2006-05-023770","volume":"109","author":"L Cervantes-Barragan","year":"2007","unstructured":"Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109, 1131\u20131137 (2007).","journal-title":"Blood"},{"key":"36140_CR39","doi-asserted-by":"publisher","first-page":"108943","DOI":"10.1016\/j.celrep.2021.108943","volume":"34","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. Cell-type-specific immune dysregulation in severely ill COVID-19 patients. Cell Rep. 34, 108943 (2021).","journal-title":"Cell Rep."},{"key":"36140_CR40","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JVI.00985-20","volume":"94","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden, A. et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J. Virol. 94, e00985\u201320 (2020).","journal-title":"J. Virol."},{"key":"36140_CR41","doi-asserted-by":"publisher","first-page":"e2022643118","DOI":"10.1073\/pnas.2022643118","volume":"118","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl Acad. Sci. USA 118, e2022643118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36140_CR42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 e1039 (2020).","journal-title":"Cell"},{"key":"36140_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41590-021-00942-0","volume":"22","author":"T Yamada","year":"2021","unstructured":"Yamada, T. et al. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat. Immunol. 22, 820\u2013828 (2021).","journal-title":"Nat. Immunol."},{"key":"36140_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27, 883\u2013890 e882 (2020).","journal-title":"Cell Host Microbe"},{"key":"36140_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1078\/0171-2985-00128","volume":"205","author":"S Berchtold","year":"2002","unstructured":"Berchtold, S. et al. Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology 205, 231\u2013246 (2002).","journal-title":"Immunobiology"},{"key":"36140_CR46","doi-asserted-by":"publisher","first-page":"584626","DOI":"10.3389\/fimmu.2020.584626","volume":"11","author":"F Antonangeli","year":"2020","unstructured":"Antonangeli, F. et al. Regulation of PD-L1 expression by NF-kappaB in cancer. Front. Immunol. 11, 584626 (2020).","journal-title":"Front. Immunol."},{"key":"36140_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.004","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2020.04.004 (2020).","journal-title":"Cell Host Microbe"},{"key":"36140_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4049\/jimmunol.137.4.1270","volume":"137","author":"R Rothlein","year":"1986","unstructured":"Rothlein, R., Dustin, M. L., Marlin, S. D. & Springer, T. A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137, 1270\u20131274 (1986).","journal-title":"J. Immunol."},{"key":"36140_CR49","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.chom.2019.03.005","volume":"25","author":"S Assil","year":"2019","unstructured":"Assil, S. et al. Plasmacytoid dendritic cells and infected cells form an interferogenic synapse required for antiviral responses. Cell Host Microbe 25, 730\u2013745 e736 (2019).","journal-title":"Cell Host Microbe"},{"key":"36140_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3492","volume":"14","author":"JD Rotty","year":"2013","unstructured":"Rotty, J. D., Wu, C. & Bear, J. E. New insights into the regulation and cellular functions of the ARP2\/3 complex. Nat. Rev. Mol. Cell Biol. 14, 7\u201312 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"36140_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200206043","volume":"159","author":"KA DeMali","year":"2002","unstructured":"DeMali, K. A., Barlow, C. A. & Burridge, K. Recruitment of the Arp2\/3 complex to vinculin: coupling membrane protrusion to matrix adhesion. J. Cell Biol. 159, 881\u2013891 (2002).","journal-title":"J. Cell Biol."},{"key":"36140_CR52","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1021\/bi501181p","volume":"53","author":"KA DeMali","year":"2014","unstructured":"DeMali, K. A., Sun, X. & Bui, G. A. Force transmission at cell-cell and cell-matrix adhesions. Biochemistry 53, 7706\u20137717 (2014).","journal-title":"Biochemistry"},{"key":"36140_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1242\/jcs.018564","volume":"122","author":"M Vicente-Manzanares","year":"2009","unstructured":"Vicente-Manzanares, M., Choi, C. K. & Horwitz, A. R. Integrins in cell migration\u2013the actin connection. J. Cell Sci. 122, 199\u2013206 (2009).","journal-title":"J. Cell Sci."},{"key":"36140_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"36140_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24360-w","volume":"12","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke, L. et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 12, 4117 (2021).","journal-title":"Nat. Commun."},{"key":"36140_CR56","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle, D., Sharif, K., O\u2019Regan, A. & Bridgewood, C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19, 102537 (2020).","journal-title":"Autoimmun. Rev."},{"key":"36140_CR57","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","volume":"40","author":"A Mildner","year":"2014","unstructured":"Mildner, A. & Jung, S. Development and function of dendritic cell subsets. Immunity 40, 642\u2013656 (2014).","journal-title":"Immunity"},{"key":"36140_CR58","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563\u2013604 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"36140_CR59","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2009-08-239145","volume":"115","author":"J Shaw","year":"2010","unstructured":"Shaw, J., Wang, Y. H., Ito, T., Arima, K. & Liu, Y. J. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood 115, 3051\u20133057 (2010).","journal-title":"Blood"},{"key":"36140_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1399-0039.2004.00159.x","volume":"63","author":"J Gomez","year":"2004","unstructured":"Gomez, J. et al. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood. Tissue Antigens 63, 149\u2013157 (2004).","journal-title":"Tissue Antigens"},{"key":"36140_CR61","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fimmu.2019.01312","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. CD83: activation marker for antigen presenting cells and its therapeutic potential. Front. Immunol. 10, 1312 (2019).","journal-title":"Front. Immunol."},{"key":"36140_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41590-017-0012-z","volume":"19","author":"SG Alculumbre","year":"2018","unstructured":"Alculumbre, S. G. et al. Diversification of human plasmacytoid predendritic cells in response to a single stimulus. Nat. Immunol. 19, 63\u201375 (2018).","journal-title":"Nat. Immunol."},{"key":"36140_CR63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/icb.2015.116","volume":"94","author":"C Bryant","year":"2016","unstructured":"Bryant, C. et al. A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset. Immunol. Cell Biol. 94, 447\u2013457 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"36140_CR64","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.4049\/jimmunol.0802008","volume":"182","author":"T Matsui","year":"2009","unstructured":"Matsui, T. et al. CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J. Immunol. 182, 6815\u20136823 (2009).","journal-title":"J. Immunol."},{"key":"36140_CR65","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"AC Villani","year":"2017","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","journal-title":"Science"},{"key":"36140_CR66","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1073\/pnas.1610630114","volume":"114","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes. Proc. Natl Acad. Sci. USA 114, 1988\u20131993 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36140_CR67","doi-asserted-by":"publisher","first-page":"e2257","DOI":"10.1371\/journal.pntd.0002257","volume":"7","author":"M Gandini","year":"2013","unstructured":"Gandini, M. et al. Dengue virus activates membrane TRAIL relocalization and IFN-alpha production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl. Trop. Dis. 7, e2257 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"36140_CR68","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1182\/blood-2009-06-224741","volume":"115","author":"R Colisson","year":"2010","unstructured":"Colisson, R. et al. Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood 115, 2177\u20132185 (2010).","journal-title":"Blood"},{"key":"36140_CR69","doi-asserted-by":"publisher","first-page":"e1261240","DOI":"10.1080\/2162402X.2016.1261240","volume":"6","author":"C Achard","year":"2017","unstructured":"Achard, C. et al. Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells. Oncoimmunology 6, e1261240 (2017).","journal-title":"Oncoimmunology"},{"key":"36140_CR70","doi-asserted-by":"crossref","unstructured":"Webster, B. et al. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses. Elife 7, e34273 (2018).","DOI":"10.7554\/eLife.34273"},{"key":"36140_CR71","doi-asserted-by":"crossref","unstructured":"Chen, D. Y. et al. SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway. J. Virol. 95, e0086221 (2021).","DOI":"10.1128\/JVI.00862-21"},{"key":"36140_CR72","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/infdis\/jiaa356","volume":"222","author":"D Yang","year":"2020","unstructured":"Yang, D. et al. Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J. Infect. Dis. 222, 734\u2013745 (2020).","journal-title":"J. Infect. Dis."},{"key":"36140_CR73","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","volume":"603","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Bastard, P., Effort, C. H. G., Cobat, A. & Casanova, J. L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603, 587\u2013598 (2022).","journal-title":"Nature"},{"key":"36140_CR74","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210\u20131220 (2020).","journal-title":"Science"},{"key":"36140_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21310-4","volume":"12","author":"A Benard","year":"2021","unstructured":"Benard, A. et al. Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections. Nat. Commun. 12, 1112 (2021).","journal-title":"Nat. Commun."},{"key":"36140_CR76","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","volume":"21","author":"A Abbas","year":"2020","unstructured":"Abbas, A. et al. The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nat. Immunol. 21, 983\u2013997 (2020).","journal-title":"Nat. Immunol."},{"key":"36140_CR77","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fimmu.2019.01088","volume":"10","author":"JW Rhodes","year":"2019","unstructured":"Rhodes, J. W., Tong, O., Harman, A. N. & Turville, S. G. Human dendritic cell subsets, ontogeny, and impact on HIV infection. Front. Immunol. 10, 1088 (2019).","journal-title":"Front. Immunol."},{"key":"36140_CR78","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.immuni.2018.03.020","volume":"48","author":"M Macal","year":"2018","unstructured":"Macal, M. et al. Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection. Immunity 48, 730\u2013744 e735 (2018).","journal-title":"Immunity"},{"key":"36140_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00695-1","volume":"8","author":"A Combes","year":"2017","unstructured":"Combes, A. et al. BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells. Nat. Commun. 8, 913 (2017).","journal-title":"Nat. Commun."},{"key":"36140_CR80","doi-asserted-by":"crossref","unstructured":"Yun, T. J. et al. Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells. Sci. Immunol. 6, eabc7302 (2021).","DOI":"10.1126\/sciimmunol.abc7302"},{"key":"36140_CR81","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.cellsig.2013.04.010","volume":"25","author":"MA Olayioye","year":"2013","unstructured":"Olayioye, M. A., Barisic, S. & Hausser, A. Multi-level control of actin dynamics by protein kinase D. Cell Signal. 25, 1739\u20131747 (2013).","journal-title":"Cell Signal."},{"key":"36140_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01687-x","volume":"8","author":"SI Saitoh","year":"2017","unstructured":"Saitoh, S. I. et al. TLR7 mediated viral recognition results in focal type I interferon secretion by dendritic cells. Nat. Commun. 8, 1592 (2017).","journal-title":"Nat. Commun."},{"key":"36140_CR83","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.humimm.2009.07.005","volume":"70","author":"Y Jing","year":"2009","unstructured":"Jing, Y. et al. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum. Immunol. 70, 777\u2013784 (2009).","journal-title":"Hum. Immunol."},{"key":"36140_CR84","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/cells10030708","volume":"10","author":"E Feng","year":"2021","unstructured":"Feng, E., Balint, E., Poznanski, S. M., Ashkar, A. A. & Loeb, M. Aging and interferons: impacts on inflammation and viral disease outcomes. Cells 10, 708 (2021).","journal-title":"Cells"},{"key":"36140_CR85","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.xcrm.2020.100059","volume":"1","author":"A Pizzorno","year":"2020","unstructured":"Pizzorno, A. et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep. Med. 1, 100059 (2020).","journal-title":"Cell Rep. Med."},{"key":"36140_CR86","doi-asserted-by":"publisher","first-page":"e1003440","DOI":"10.1371\/journal.ppat.1003440","volume":"9","author":"B de Chassey","year":"2013","unstructured":"de Chassey, B. et al. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog. 9, e1003440 (2013).","journal-title":"PLoS Pathog."},{"key":"36140_CR87","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.chom.2012.08.010","volume":"12","author":"M Dreux","year":"2012","unstructured":"Dreux, M. et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558\u2013570 (2012).","journal-title":"Cell Host Microbe"},{"key":"36140_CR88","doi-asserted-by":"crossref","unstructured":"Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J. Virol. 95, e02415-20 (2021).","DOI":"10.1128\/JVI.02415-20"},{"key":"36140_CR89","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1099\/vir.0.81749-0","volume":"87","author":"X Ren","year":"2006","unstructured":"Ren, X. et al. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J. Gen. Virol. 87, 1691\u20131695 (2006).","journal-title":"J. Gen. Virol."},{"key":"36140_CR90","doi-asserted-by":"publisher","first-page":"9470","DOI":"10.1128\/JVI.79.15.9470-9479.2005","volume":"79","author":"C-TK Tseng","year":"2005","unstructured":"Tseng, C.-T. K. et al. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized calu-3 lung epithelial cells. J. Virol. 79, 9470\u20139479 (2005).","journal-title":"J. Virol."},{"key":"36140_CR91","doi-asserted-by":"publisher","first-page":"e1009500","DOI":"10.1371\/journal.ppat.1009500","volume":"17","author":"M Laporte","year":"2021","unstructured":"Laporte, M. et al. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways. PLoS Pathog. 17, e1009500 (2021).","journal-title":"PLoS Pathog."},{"key":"36140_CR92","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cyto.2018.10.023","volume":"113","author":"R Pescarmona","year":"2019","unstructured":"Pescarmona, R. et al. Comparison of RT-qPCR and nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies. Cytokine 113, 446\u2013452 (2019).","journal-title":"Cytokine"},{"key":"36140_CR93","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/2211068215589580","volume":"21","author":"DH Wilson","year":"2016","unstructured":"Wilson, D. H. et al. The simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J. Lab. Autom. 21, 533\u2013547 (2016).","journal-title":"J. Lab. Autom."},{"key":"36140_CR94","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman, J. H. Greedy function approximation: a gradient boosting machine. Ann. Stat. 29, 1189\u20131232, 1144 (2001).","journal-title":"Ann. Stat."},{"key":"36140_CR95","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0167-9473(01)00065-2","volume":"38","author":"JH Friedman","year":"2002","unstructured":"Friedman, J. H. Stochastic gradient boosting. Comput. Stat. Data Anal. 38, 367\u2013378 (2002).","journal-title":"Comput. Stat. Data Anal."},{"key":"36140_CR96","unstructured":"Hastie, T., Tibshirani, R. & Friedman, J. in Springer Nature. Vol. Ed. 2 (2009)."},{"key":"36140_CR97","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"36140_CR98","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","volume":"27","author":"CE Grant","year":"2011","unstructured":"Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017\u20131018 (2011).","journal-title":"Bioinformatics"},{"key":"36140_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-165","volume":"11","author":"RC McLeay","year":"2010","unstructured":"McLeay, R. C. & Bailey, T. L. Motif Enrichment Analysis: a unified framework and an evaluation on ChIP data. BMC Bioinformatics 11, 165 (2010).","journal-title":"BMC Bioinformatics"},{"key":"36140_CR100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36140-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T20:52:17Z","timestamp":1728852737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36140"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36140-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"694"}}